that ^ red dye, the hydrochloride of 4-sulphamido-2:4-diamino azo-benzol (VII), had a specific action against haemolytic streptococci. It was clinically tested by Klee and Romer (1935) , Schreus (1935) and Levaditi and Vaisman (1935) . As Trefouel et al. (1935) that the azo compounds which did not contain a sulphonamide group attached to one benzene nucleus were inactive, whereas the substituents in the other nucleus might be varied without influencing the protective power. They further noted that the diazo-linkage itself was not essential and that the parent compound p-aminobenzenesulphonamide (VI) was equally therapeutically active?an observation since confirmed by Colebook and Kenny (1936) . Colebrook et al. (1936) have further observed that p-aminobenzene-sulphonamide has a bacteriostatic and bactericidal action against a small number of haemolytic streptococci in culture media and in blood, whereas the red dye, better known as prontosil-red, is inactive. On reduction, however, it affords an active substance indicating thereby that the prontosil may become altered in the system to give rise to the active substance sulphonamide. That reduction may be the factor in the activation of prontosil seems also reasonable from the fact that haemolytic streptococci can, under certain conditions, bring about the reduction of some chemical substances. The proof (Fuller, 1937 (Gray et al., 1937) . That the activity of p-acetyl-aminobenzene-sulphonamide (V) is one-third of that of sulphonamide (Buttle et al., 1936) (Fourneau et al., 1937 weight is about 150 mgm. (Whitby, 1937) . This is several times the full effective dosage; our investigations (De and Basu, 1937) [Jan., 1938 formation of methemoglobinemia, when inhalation of oxygen would help in its disappearance within a day (Paton and Eaton, 1937 (Kolm, 1937) , toxic optic neuritis' (Bucy, 1937) Fuge (1935) treated 120 patients suffering from puerperal fever with large doses of prontosil-red and only three died. Ley (1936) reports good results in a number of cases and regards this treatment as superior to other medicaments. Recently, Foulis and Barr (1937) have treated 22 cases of puerperal septicaemia with prontosil album (sulphonamide) with successful result and the drug was tolerated even in large doses. In their study with several cases Colebrook and Kenny (1936) observed the development of sulphaemoglobinaemia in 3 out of 38 patients. A peculiar case of chronic wound infection due to haemolytic streptococci following puerperal sepsis due to the same organism three years previously is described by Purdie and Fry (1937 (ii) Erysipelas /: Gmelin (1935) treated 10 children with erysipelas and observed rapid improvement. In a comparative study Kramer (1936) (Schwentker et al., 1937) . Similarly Anderson (1937) (Anwyl-Davies, 1937) . However, certain cases have been successfully treated with this new drug. Dees and Colston (1937) Recknagel (1935) in tonsillitis, pneumonia and rheumatoid arthritis, prontosil-red was also successfully used in 3 cases of typhus (Schmidt, 1936) . In affections of the skin and mucous membrane, Jaeger (1936) advocates its local application. He also used it locally in a solution or as dressing in wounds, boils, carbuncles, eczema and various fungus infections of the skin. In cases of Ludwig's angina and cellulitis of the legs with septicaemia death has, however, been recorded (Long and Bliss, 1937a) . Quite recently (Van der Wielen, 1937) , prontosil has been used in a case of quartan malaria with apparent success.
Conclusion
Previous to the discovery of this drug puerperal fever and other streptococcal diseases were generally treated with biological products which arc usually inconvenient and have other drawbacks. It is now evident that the sulphonamide for its rapidity of action and simplicity of administration is being found to be specially valuable in various streptococcal and other bacterial infections. Its cheapness in comparison with other medicaments is also an additional advantage. Of course, as already pointed out, the consequences of its use are increasing in complexity. Moreover, it has been recently shown (Bliss and Long, 1937) that the compound has no bacteriostatic action against organisms of group D (Lancefield) beta-haemolytic streptococci and the minute members of group G i>efo-haemolytic streptococci. This [Jan., 1938 probably means that a more scientific classification of the infecting streptococcus before administration of the drug would probably ensure better clinical results. It is, however, beyond dispute that if after proper bacteriological examination the correct dosage and method of administration be followed, the drug would be found to be specific in certain bacterial infections. Lastly, it must be remembered that though the drug holds out promise of great usefulness, caution should be observed with its treatment and, even if no serious toxic effect be noticed, it is advisable that the patient should be kept under close careful medical observation.
